Genitourinary Cancer
Practical Radiation Oncology
AMA PRA Category 1 Credits 1.25
CAMPEP Credits: 1.25
MDCB Credits: 1.25
Sean Collins, MD, PhD
Tampa General Hospital
Arlington, VA
Conventionally fractionated external beam radiation therapy (EBRT) has a long-standing track record of safety and excellent treatment outcomes in the management of all prostate cancer risk groups. With modern external beam radiation therapy techniques such as stereotactic body radiation therapy (SBRT) prostate cancer patients can now be treated safely with just a few fractions. SBRT is cost-effective and easy to implement in academic centers. With the recently announced PACE B primary outcome - that ultra-hypofractionated radiotherapy is non-inferior to standard radiotherapy for patients with low- and favorable intermediate-risk cancer, we expect that adoption of this regimen will accelerate further. Ultimately, whether SBRT can replace conventionally fractionated EBRT in the community is not known but will be the topic of this session. This session is intended to guide the community practitioner in developing their own prostate SBRT practice. The session will begin with a discussion around the evidence supporting 5-fraction prostate SBRT. Next, we will provide some guidance regarding practice management. The third speaker will discuss how to safely deliver ultra-hypofractionated radiation in the community.
Speaker: Beant Gill, MD – Associates in Radiation Medicine
Speaker: Sean Collins, MD, PhD – Tampa General Hospital
Speaker: Nicholas van As, MD, MB – The Royal Marsden NHS Foundation Trust
Speaker: Jonathan Haas, MD – NYU Langone Health - Long Island
Speaker: Michael Zelefsky, MD, FASTRO – NYU Langone Health
Speaker: Sean Collins, MD, PhD – Tampa General Hospital